Marco Cavaleri is Head of Department, Public Health Threats. He is the Chair of EMA Emergency Task Force (ETF) and responsible for EMA activities for emergent pathogens, vaccines and AMR. He has been leading the EMA activities during the COVID-19 pandemic on vaccines and therapeutics.
He serves in different advisory groups at WHO, including PDVAC, R&D Blueprint TAG on prioritisation of therapeutics and clinical trials working group. Marco Cavaleri is a Pharmacologist who spent several years in industry in R&D mainly in the area of anti-infectives covering different positions in preclinical and clinical development of new antibacterial, antitubercular and antifungal agents.
He has expertise in microbiology, animal models, vaccines, translational science and clinical trials.He is co-author of several publications related to vaccines, infectious diseases and regulation of medicines.